TransAct Technologies (TACT) awards 15,000 RSUs to CMO under equity plan

Rhea-AI Filing Summary

TransAct Technologies reported an equity grant to its Chief Marketing Officer, Dana Loof. On December 15, 2025, Loof received 15,000 Restricted Stock Units under the company’s 2014 Equity Incentive Plan, as Amended and Restated.

The restricted stock units cliff vest on the second anniversary of the grant date, meaning all 15,000 units vest at once two years after December 15, 2025. Upon vesting, each unit converts into one share of TransAct common stock on a one-for-one basis. Following this grant, Loof beneficially owns 15,000 derivative securities, held directly.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Loof Dana

(Last) (First) (Middle)

ONE HAMDEN CENTER

2319 WHITNEY AVENUE, SUITE 3B

(Street)

HAMDEN CT 06518

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
TRANSACT TECHNOLOGIES INC [ TACT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Marketing Officer

3. Date of Earliest Transaction (Month/Day/Year)
12/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	12/15/2025		A		15,000		(1)	(1)	Common Stock	15,000	$0(1)	15,000	D

Explanation of Responses:

1. Restricted Stock Units issued on December 15, 2025 pursuant to the Company's 2014 Equity Incentive Plan, as Amended and Restated, with shares cliff vesting on the second anniversary date of the grant and converting to common stock on a one-for-one basis.

	/s/ Madison Gallagher, Attorney-in-Fact	01/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did TACT report in this Form 4?

The filing reports that TransAct Technologies granted 15,000 Restricted Stock Units to its Chief Marketing Officer, Dana Loof, on December 15, 2025.

Who is the reporting person in the TransAct Technologies (TACT) Form 4?

The reporting person is Dana Loof, who serves as Chief Marketing Officer of TransAct Technologies.

How many Restricted Stock Units were granted to the TransAct CMO and at what price?

Dana Loof was granted 15,000 Restricted Stock Units, reported with a per-unit price of $0.00 as an equity award under the company’s incentive plan.

What are the vesting terms of the 15,000 RSUs granted by TransAct Technologies?

The 15,000 RSUs issued on December 15, 2025 cliff vest on the second anniversary of the grant date, so they vest in full two years after that date.

How do the RSUs for TACT’s CMO convert into common stock?

Once vested, each Restricted Stock Unit converts into one share of TransAct common stock on a one-for-one basis, according to the filing’s footnote.

How many derivative securities does the TransAct CMO own after this grant?

After the reported transaction, Dana Loof beneficially owns 15,000 derivative securities (Restricted Stock Units), all held directly.

Under which plan were the RSUs to the TransAct CMO granted?

The Restricted Stock Units were granted under TransAct Technologies’ 2014 Equity Incentive Plan, as Amended and Restated.